We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 9.84%
3 Healthcare 7.45%
4 Communication Services 7.19%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCBI icon
4101
CALL
Texas Capital Bancshares
TCBI
$4.31B
$305K ﹤0.01%
4,800
-5,100
-52% -$344K
ZYME icon
4102
Zymeworks
ZYME
$1.68B
$305K ﹤0.01%
8,784
-10,558
-55% -$335K
OBIO icon
4103
Orchestra BioMed
OBIO
$224M
$304K ﹤0.01%
+29,801
New +$308K
TMP icon
4104
Tompkins Financial
TMP
$1.45B
$304K ﹤0.01%
3,922
-1,881
-32% -$151K
USFD icon
4105
US Foods
USFD
$21.4B
$304K ﹤0.01%
7,913
-104,199
-93% -$4.04M
AUS.WS
4106
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$303K ﹤0.01%
+174,999
New +$253K
NPO icon
4107
Enpro
NPO
$7.05B
$302K ﹤0.01%
3,105
-4,791
-61% -$438K
AGYS icon
4108
Agilysys
AGYS
$2.78B
$301K ﹤0.01%
5,285
-1,113
-17% -$57.6K
DZSI
4109
DELISTED
DZS Inc. Common Stock
DZSI
$301K ﹤0.01%
+14,497
New +$252K
CFR icon
4110
Cullen/Frost Bankers
CFR
$10.3B
$300K ﹤0.01%
2,678
+360
+16% +$42.1K
CODX
4111
Co-Diagnostics
CODX
$7.74M
$299K ﹤0.01%
+1,208
New +$311K
EVV
4112
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
$298K ﹤0.01%
22,500
NXTC icon
4113
NextCure
NXTC
$17.3M
$297K ﹤0.01%
3,083
-613
-17% -$62.7K
SI
4114
DELISTED
Silvergate Capital Corporation
SI
$297K ﹤0.01%
2,620
-407
-13% -$46.1K
ATEC icon
4115
Alphatec Holdings
ATEC
$1.27B
$296K ﹤0.01%
+19,331
New +$298K
EVI icon
4116
EVI Industries
EVI
$180M
$296K ﹤0.01%
10,428
+319
+3% +$9.33K
PVLA
4117
Palvella Therapeutics
PVLA
$1.98B
$296K ﹤0.01%
968
+729
+305% +$160K
VISN
4118
Vistance Networks Inc
VISN
$2.66B
$295K ﹤0.01%
+13,839
New +$258K
SGMO
4119
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$295K ﹤0.01%
24,645
-47,063
-66% -$533K
POWRU
4120
DELISTED
Powered Brands Units
POWRU
$294K ﹤0.01%
+29,330
New +$293K
PTVE
4121
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$293K ﹤0.01%
+19,433
New +$292K
BMRC icon
4122
Bank of Marin Bancorp
BMRC
$466M
$292K ﹤0.01%
+9,149
New +$320K
ESGR
4123
DELISTED
Enstar Group
ESGR
$292K ﹤0.01%
1,223
+21
+2% +$5.22K
AVGO icon
4124
Broadcom
AVGO
$1.82T
$291K ﹤0.01%
6,110
-198,440
-97% -$9.2M
FOR icon
4125
Forestar Group
FOR
$1.44B
$291K ﹤0.01%
13,935
-6,452
-32% -$151K

Similar funds

D.E. Shaw & Co's Q2 2021 Portfolio in Review

As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.